These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34229082)

  • 1. Systematic risk identification and assessment using a new risk map in pharmaceutical R&D.
    Schuhmacher A; Brieke C; Gassmann O; Hinder M; Hartl D
    Drug Discov Today; 2021 Dec; 26(12):2786-2793. PubMed ID: 34229082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Big Techs and startups in pharmaceutical R&D - A 2020 perspective on artificial intelligence.
    Schuhmacher A; Gatto A; Kuss M; Gassmann O; Hinder M
    Drug Discov Today; 2021 Oct; 26(10):2226-2231. PubMed ID: 33965571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of artificial intelligence to enhance phenotypic drug discovery.
    Malandraki-Miller S; Riley PR
    Drug Discov Today; 2021 Apr; 26(4):887-901. PubMed ID: 33484947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry's Views.
    Mayer M; Canedo A; Dinh T; Low M; Ortiz A; Garay C
    Ther Innov Regul Sci; 2019 Nov; 53(6):759-766. PubMed ID: 30522348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R&D efficiency of leading pharmaceutical companies - A 20-year analysis.
    Schuhmacher A; Wilisch L; Kuss M; Kandelbauer A; Hinder M; Gassmann O
    Drug Discov Today; 2021 Aug; 26(8):1784-1789. PubMed ID: 34022459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building the future of drug discovery.
    Bloom B
    Drug Discov Today; 2021 Apr; 26(4):863-864. PubMed ID: 33548463
    [No Abstract]   [Full Text] [Related]  

  • 7. Reviving an R&D pipeline: a step change in the Phase II success rate.
    Wu SS; Fernando K; Allerton C; Jansen KU; Vincent MS; Dolsten M
    Drug Discov Today; 2021 Feb; 26(2):308-314. PubMed ID: 33129994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating target engagement of small molecules via drug delivery: approaches and applications in drug discovery and development.
    Yang W; Bhattachar SN; Patel PJ; Landis M; Patel D; Reid DL; Duvnjak Romic M
    Drug Discov Today; 2021 Mar; 26(3):713-723. PubMed ID: 33333320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research and development productivity map: visualization of industry status.
    Shimura H; Masuda S; Kimura H
    J Clin Pharm Ther; 2014 Apr; 39(2):175-80. PubMed ID: 24438433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Machine Learning in Translational Medicine: Current Status and Future Opportunities.
    Terranova N; Venkatakrishnan K; Benincosa LJ
    AAPS J; 2021 May; 23(4):74. PubMed ID: 34008139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can quantitative pharmacology improve productivity in pharmaceutical research and development?
    Patel M; Bueters T
    Expert Opin Drug Discov; 2020 Oct; 15(10):1111-1114. PubMed ID: 32511018
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
    Kashyap K; Siddiqi MI
    Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to improve R&D productivity: the pharmaceutical industry's grand challenge.
    Paul SM; Mytelka DS; Dunwiddie CT; Persinger CC; Munos BH; Lindborg SR; Schacht AL
    Nat Rev Drug Discov; 2010 Mar; 9(3):203-14. PubMed ID: 20168317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models for open innovation in the pharmaceutical industry.
    Schuhmacher A; Germann PG; Trill H; Gassmann O
    Drug Discov Today; 2013 Dec; 18(23-24):1133-7. PubMed ID: 23892183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review.
    Kolluri S; Lin J; Liu R; Zhang Y; Zhang W
    AAPS J; 2022 Jan; 24(1):19. PubMed ID: 34984579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The revolution of AI in drug development].
    Moingeon P; Garbay C; Dahan M; Fermont I; Benmakhlouf A; Gouyette A; Poitou P; Saint-Pierre A;
    Med Sci (Paris); 2024 Apr; 40(4):369-376. PubMed ID: 38651962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developability assessment in pharmaceutical industry: An integrated group approach for selecting developable candidates.
    Saxena V; Panicucci R; Joshi Y; Garad S
    J Pharm Sci; 2009 Jun; 98(6):1962-79. PubMed ID: 18855914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Big Data and Artificial Intelligence Modeling for Drug Discovery.
    Zhu H
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():573-589. PubMed ID: 31518513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lesson from Japan: research and development efficiency is a key element of pharmaceutical industry consolidation process.
    Shimura H; Masuda S; Kimura H
    Drug Discov Ther; 2014 Feb; 8(1):57-63. PubMed ID: 24647159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.